Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review
AbstractBiomarker-guided treatment is a rapidly developing area of medicine, where treatment choice is personalised according to one or more of an individual’s biomarker measurements. A number of biomarker-guided trial designs have been proposed in the past decade, including both adaptive and non-adaptive trial designs which test the effectiveness of a biomarker-guided approach to treatment with the aim of improving patient health. A better understanding of them is needed as challenges occur both in terms of trial design and analysis. We have undertaken a comprehensive literature review based on an in-depth search strategy with a view to providing the research community with clarity in definition, methodology and terminology of the various biomarker-guided trial designs (both adaptive and non-adaptive designs) from a total of 211 included papers. In the present paper, we focus on non-adaptive biomarker-guided trial designs for which we have identified five distinct main types mentioned in 100 papers. We have graphically displayed each non-adaptive trial design and provided an in-depth overview of their key characteristics. Substantial variability has been observed in terms of how trial designs are described and particularly in the terminology used by different authors. Our comprehensive review provides guidance for those designing biomarker-guided trials. View Full-Text
- Supplementary File 1:
Supplementary (PDF, 527 KB)
Externally hosted supplementary file 1
Description: S1 Keywords. Literature review search strategies for both biomarker-guided clinical trial designs and for traditional trial designs.
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Antoniou, M.; Kolamunnage-Dona, R.; Jorgensen, A.L. Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review. J. Pers. Med. 2017, 7, 1.
Antoniou M, Kolamunnage-Dona R, Jorgensen AL. Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review. Journal of Personalized Medicine. 2017; 7(1):1.Chicago/Turabian Style
Antoniou, Miranta; Kolamunnage-Dona, Ruwanthi; Jorgensen, Andrea L. 2017. "Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review." J. Pers. Med. 7, no. 1: 1.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.